As of Jun 24
| -0.0491 / -9.86%|
The 4 analysts offering 12-month price forecasts for Orexigen Therapeutics Inc have a median target of 0.80, with a high estimate of 2.00 and a low estimate of 0.50. The median estimate represents a +78.25% increase from the last price of 0.45.
The current consensus among 6 polled investment analysts is to Hold stock in Orexigen Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.